MARKET

PBLA

PBLA

Panbela Therapeutics Inc
NASDAQ
0.4377
+0.0156
+3.70%
Opening 12:20 03/31 EDT
OPEN
0.4200
PREV CLOSE
0.4221
HIGH
0.4395
LOW
0.4200
VOLUME
349.92K
TURNOVER
94.75K
52 WEEK HIGH
87.60
52 WEEK LOW
0.4100
MARKET CAP
6.39M
P/E (TTM)
-0.0051
1D
5D
1M
3M
1Y
5Y
Health Care Sector Update for 03/22/2023: ETNB, PBLA, NEO
NASDAQ · 03/22 17:29
Panbela Announces Issuance Of New Patent In Japan; Patent Is For Claims Of A Novel Process For The Production Of SBP-101
Benzinga · 03/22 12:39
Panbela Therapeutics Secures Patent in Japan; Shares Rise
Panbela Therapeutics Secures Patent in Japan; Shares Rise
MT Newswires · 03/22 12:17
Maxim Group Upgrades Panbela Therapeutics (PBLA)
NASDAQ · 03/21 09:47
Benzinga's Top Ratings Upgrades, Downgrades For March 20, 2023
Benzinga · 03/20 15:00
Maxim Group Upgrades Panbela Therapeutics to Buy, Announces $1.5 Price Target
Benzinga · 03/20 13:36
--Maxim Upgrades Panbela Therapeutics to Buy From Hold, Price Target is $1.50
--Maxim Upgrades Panbela Therapeutics to Buy From Hold, Price Target is $1.50
MT Newswires · 03/20 10:14
Why Baidu Shares Are Trading Higher By More Than 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga · 03/17 16:49
More
About PBLA
Panbela Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on developing disruptive therapeutics for the treatment of patients with cancer. Its primary focus is on the treatment of patients with pancreatic cancer. Its lead product candidate, SBP-101, is a polyamine analogue designed to induce polyamine metabolic inhibition (PMI) by exploiting an observed high affinity of the compound for pancreatic ductal adenocarcinoma, ovarian cancer and other tumors. The Company is conducting Phase Ia/Ib study of the safety, tolerability and pharmacokinetics of SBP-101 when administered in combination with gemcitabine and nab-paclitaxel.

Webull offers kinds of Panbela Therapeutics Inc stock information, including NASDAQ:PBLA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PBLA stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading PBLA stock methods without spending real money on the virtual paper trading platform.